Difference between revisions of "Team:Tsinghua/MedalChecklist"

Line 174: Line 174:
 
                       <h2 class="contentPage">Register and attend</h2>
 
                       <h2 class="contentPage">Register and attend</h2>
 
                       <font color="#ff6699">✔</font> We have registered for iGEM, enjoyed a great summer, and will attend the Giant Jamboree.</ul>
 
                       <font color="#ff6699">✔</font> We have registered for iGEM, enjoyed a great summer, and will attend the Giant Jamboree.</ul>
 +
                      <br>
 
                       <h2 class="contentPage">Deliverables</h2>
 
                       <h2 class="contentPage">Deliverables</h2>
 
                       <font color="#ff6699">✔</font> We have created a Team Wiki and submitted the judging form as well as the safety form. We will<br>
 
                       <font color="#ff6699">✔</font> We have created a Team Wiki and submitted the judging form as well as the safety form. We will<br>
 
                       present a poster and a talk at the Giant Jamboree.</ul>
 
                       present a poster and a talk at the Giant Jamboree.</ul>
 +
                      <br>
 
                       <h2 class="contentPage">Attribution</h2>
 
                       <h2 class="contentPage">Attribution</h2>
 
                       <font color="#ff6699">✔</font> We have our <a href="https://2016.igem.org/Team:Tsinghua/Attributions">Attribution page</a></ul>
 
                       <font color="#ff6699">✔</font> We have our <a href="https://2016.igem.org/Team:Tsinghua/Attributions">Attribution page</a></ul>
 +
                      <br>
 
                       <h2 class="contentPage">Part / Contribution</h2>
 
                       <h2 class="contentPage">Part / Contribution</h2>
 
                       <font color="#ff6699">✔</font> Our C2c2 and RT BioBrick containing Class 2 type VI-A CRISPR-Cas effector C2c2, and reverse<br>
 
                       <font color="#ff6699">✔</font> Our C2c2 and RT BioBrick containing Class 2 type VI-A CRISPR-Cas effector C2c2, and reverse<br>
Line 191: Line 194:
 
                       <font color="#ff6699">✔</font> We have validated our NLS-FLAG-EGFP-dCas9-NLS and Thymine kinase BioBrick with the methods<br>
 
                       <font color="#ff6699">✔</font> We have validated our NLS-FLAG-EGFP-dCas9-NLS and Thymine kinase BioBrick with the methods<br>
 
                       described here. And we already submitted these new parts to the iGEM Parts Registry.</ul>
 
                       described here. And we already submitted these new parts to the iGEM Parts Registry.</ul>
 +
                      <br>
 
                       <h2 class="contentPage">Collaboration</h2>
 
                       <h2 class="contentPage">Collaboration</h2>
 
                       <font color="#ff6699">✔</font> Tsinghua team beishida</ul>
 
                       <font color="#ff6699">✔</font> Tsinghua team beishida</ul>
 +
                      <br>
 
                       <h2 class="contentPage">Human Practices</h2>
 
                       <h2 class="contentPage">Human Practices</h2>
 
                       <font color="#ff6699">✔</font> Our <a href="https://2016.igem.org/Team:Tsinghua/Human_Practices">human practices page</a> is here.</ul>
 
                       <font color="#ff6699">✔</font> Our <a href="https://2016.igem.org/Team:Tsinghua/Human_Practices">human practices page</a> is here.</ul>

Revision as of 22:07, 19 October 2016

Medal checklist

Bronze


Register and attend

We have registered for iGEM, enjoyed a great summer, and will attend the Giant Jamboree.

Deliverables

We have created a Team Wiki and submitted the judging form as well as the safety form. We will
present a poster and a talk at the Giant Jamboree.

Attribution

We have our Attribution page

Part / Contribution

Our C2c2 and RT BioBrick containing Class 2 type VI-A CRISPR-Cas effector C2c2, and reverse
transcriptase respectively.

silver


Validated Part / Validated Contribution

We have validated our NLS-FLAG-EGFP-dCas9-NLS and Thymine kinase BioBrick with the methods
described here. And we already submitted these new parts to the iGEM Parts Registry.

Collaboration

Tsinghua team beishida

Human Practices

Our human practices page is here.

gold


Integrated Human Practices

2016 iGEM Tsinghua - All rights reserved Adapted from Bootstrap and FIVB Follow us: igem2016_tsinghua@126.com